Back to Browse Journals » Substance Abuse and Rehabilitation » Volume 2 » Issue 1

Recent national trends in Salvia divinorum use and substance-use disorders among recent and former Salvia divinorum users compared with nonusers

Authors Wu LT, Woody GE, Yang C, Li JH, Blazer DG

Published Date April 2011 Volume 2011:2(1) Pages 53—68

DOI http://dx.doi.org/10.2147/SAR.S17192

Published 4 April 2011

Li-Tzy Wu1, George E Woody2, Chongming Yang3, Jih-Heng Li4, Dan G Blazer1
1Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA; 2Department of Psychiatry, University of Pennsylvania and Treatment Research Institute, Philadelphia, PA, USA; 3Social Science Research Institute, Duke University, Durham, NC, USA; 4College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan

Context: Media and scientific reports have indicated an increase in recreational use of Salvia divinorum. Epidemiological data are lacking on the trends, prevalence, and correlates of S. divinorum use in large representative samples, as well as the extent of substance use and mental health problems among S. divinorum users.
Objective: To examine the national trend in prevalence of S. divinorum use and to identify sociodemographic, behavioral, mental health, and substance-use profiles of recent (past-year) and former users of S. divinorum.
Design: Analyses of public-use data files from the 2006–2008 United States National Surveys on Drug Use and Health (N = 166,453).
Setting: Noninstitutionalized individuals aged 12 years or older were interviewed in their places of residence.
Main measures: Substance use, S. divinorum, self-reported substance use disorders, criminality, depression, and mental health treatment were assessed by standardized survey questions administered by the audio computer-assisted self-interviewing method.
Results: Among survey respondents, lifetime prevalence of S. divinorum use had increased from 0.7% in 2006 to 1.3% in 2008 (an 83% increase). S. divinorum use was associated with ages 18–25 years, male gender, white or multiple race, residence of large metropolitan areas, arrests for criminal activities, and depression. S. divinorum use was particularly common among recent drug users, including users of lysergic acid diethylamide (53.7%), ecstasy (30.1%), heroin (24.2%), phencyclidine (22.4%), and cocaine (17.5%). Adjusted multinomial logistic analyses indicated polydrug use as the strongest determinant for recent and former S. divinorum use. An estimated 43.0% of past-year S. divinorum users and 28.9% of former S. divinorum users had an illicit or nonmedical drug-use disorder compared with 2.5% of nonusers. Adjusted logistic regression analyses showed that recent and former S. divinorum users had greater odds of having past-year depression and a substance-use disorder (alcohol or drugs) than past-year alcohol or drug users who did not use S. divinorum.
Conclusion: S. divinorum use is prevalent among recent or active drug users who have used other hallucinogens or stimulants. The high prevalence of substance use disorders among recent S. divinorum users emphasizes the need to study health risks of drug interactions.

Keywords: alcohol-use disorders, drug-use disorders, ecstasy, lysergic acid diethylamide, major depression, multiple race, nicotine dependence, phencyclidine, prescription drug abuse

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

The use of brain imaging to elucidate neural circuit changes in cocaine addiction

Hanlon CA, Canterberry M

Substance Abuse and Rehabilitation 2012, 3:115-128

Published Date: 12 September 2012

Improving drug abuse treatment delivery through adoption of harmonized electronic health record systems

Ghitza UE, Sparenborg S, Tai B

Substance Abuse and Rehabilitation 2011, 2:125-131

Published Date: 18 July 2011

Patterns and correlates of illicit drug selling among youth in the USA

Vaughn MG, Shook JJ, Perron BE, Abdon A, Ahmedani B

Substance Abuse and Rehabilitation 2011, 2:103-111

Published Date: 27 May 2011

To use or not to use: an update on licit and illicit ketamine use

Jih-Heng Li, Balasingam Vicknasingam, Yuet-wah Cheung, et al

Substance Abuse and Rehabilitation 2011, 2:11-20

Published Date: 16 March 2011

Nephroprotection of lacidipine against gentamycin-induced nephrotoxicity in albino rats

Sahar Kamal

Journal of Experimental Pharmacology 2010, 2:59-63

Published Date: 4 June 2010